Bausch Health: Q2 Beat And Cheap, But Debt Overhang Remains Substantial
AI Summary
Bausch Health reported a Q2 earnings beat and a stock price that remains cheap despite a substantial debt burden. Financial analysis notes ongoing concerns about the significant debt overshadowing the company's financial performance.